90 Participants Needed

Behavioral Program for Weight Loss

Recruiting at 1 trial location
MW
RD
AS
Overseen ByADAPT Study
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

The trial requires that you stop taking medications that significantly affect appetite, such as weight loss medications, atypical antipsychotics, and stimulants, as well as chronic use of anticoagulants.

What data supports the effectiveness of the treatment Behavioral Weight Loss Program?

Research shows that behavioral treatments can lead to a 10% weight loss, which improves health, and a comprehensive program can maintain 83% of initial weight loss after 18 months. Additionally, multistep cognitive behavioral therapy has resulted in a 15% weight loss over 12 months, with promising long-term results.12345

Is the Behavioral Program for Weight Loss safe for humans?

The research does not specifically address safety concerns, but behavioral weight loss programs are generally considered safe as they focus on lifestyle changes like diet and exercise, which are typically low-risk.56789

How is the Behavioral Weight Loss Program treatment different from other treatments for obesity?

The Behavioral Weight Loss Program is unique because it focuses on changing behaviors related to eating, exercise, and attitudes, rather than just diet or exercise alone. It involves a comprehensive approach that includes mental conditioning and social support, which helps maintain weight loss over time.1561011

What is the purpose of this trial?

Behavioral weight loss programs for obesity can result in weight loss and health benefits. However, behavioral weight loss often stops despite efforts to continue losing weight, this can be called an involuntarily weight loss plateau. This study investigates changes in metabolism and/or the brain that contribute to the occurrence of an involuntary weight loss plateau.

Research Team

MN

Marian L. Neuhouser

Principal Investigator

Fred Hutch Cancer Center

ES

Ellen Schur, MD, MS

Principal Investigator

University of Washington

JT

Jenny Tong, MD

Principal Investigator

University of Washington/VA Puget Sound

Eligibility Criteria

This trial is for individuals who are experiencing obesity and want to lose weight. Participants should be willing to follow a Behavioral Weight Loss Program but have hit an involuntary weight loss plateau despite their efforts.

Inclusion Criteria

BMI 30.0 - 50.0 kg/m2
I can attend all required study classes and visits.
Independently living with access to food preparation facilities

Exclusion Criteria

MRI contraindication (e.g., implanted metal, claustrophobia)
Do not have a phone compatible with activity tracker or access to videoconferencing platform that will be used for the dietary intervention or other appropriate technology needed to complete study procedures
Any condition(s) found by the study team and confirmed with the PI(s) that make it unsafe to participate
See 14 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Initial Study Visits

Participants complete 3 in-person study visits for baseline assessments including questionnaires, blood draws, brain MRIs, body measurements, DXA scans, breathing tests, and biopsies.

4-6 weeks
3 visits (in-person)

Weight Loss Program

Participants undergo a 6-month behavioral weight loss program delivered remotely.

6 months
Remote participation

Additional Study Visits

Some participants may be invited to complete 3 additional in-person visits for further assessments.

Variable
3 visits (in-person)

Follow-up

Participants are monitored for physiological changes and weight loss plateau occurrence.

18 months

Treatment Details

Interventions

  • Behavioral Weight Loss Program
Trial Overview The study is examining why people stop losing weight after initial success with a Behavioral Weight Loss Program, focusing on changes in metabolism and brain function that might cause this plateau.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Behavioral Weight LossExperimental Treatment1 Intervention
Participants will undergo a behavioral weight loss program.

Behavioral Weight Loss Program is already approved in United States, European Union for the following indications:

🇺🇸
Approved in United States as Behavioral Weight Loss Program for:
  • Obesity
  • Weight Loss
  • Type 2 Diabetes Prevention
🇪🇺
Approved in European Union as Behavioral Weight Loss Interventions for:
  • Obesity
  • Weight Loss
  • Type 2 Diabetes Prevention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Washington

Lead Sponsor

Trials
1,858
Recruited
2,023,000+

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Trials
2,513
Recruited
4,366,000+

Findings from Research

An interdisciplinary comprehensive weight loss program, combined with a biweekly behavioral maintenance program, helped participants maintain 83% of their initial weight loss after 18 months.
This multi-disciplinary approach, which includes social support and aerobic exercise, is considered the best current treatment for obesity, providing significant long-term health benefits.
Current treatment of obesity: a behavioral medicine perspective.Pera, V., Clark, MM., Abrams, DB.[2005]
Behavioral treatment can effectively lead to a 10% weight loss, which is significant enough to improve health outcomes for patients.
Maintaining weight loss is difficult, but long-term success can be enhanced by increasing patient-provider contact, encouraging physical activity, and combining lifestyle changes with medication.
Behavioral treatment of obesity.Butryn, ML., Webb, V., Wadden, TA.[2022]
Participants who followed a 12-month clustered campaign treatment schedule regained significantly less weight (0.35 kg) compared to those in a self-directed program (2.40 kg), indicating that structured support can help maintain weight loss after an initial treatment.
The clustered campaign approach allowed participants to maintain 87% of their weight loss, while those in the self-directed group maintained only 64%, highlighting the effectiveness of group-based support in preventing weight regain.
Comparison of an alternative schedule of extended care contacts to a self-directed control: a randomized trial of weight loss maintenance.Dutton, GR., Gowey, MA., Tan, F., et al.[2021]

References

Current treatment of obesity: a behavioral medicine perspective. [2005]
Behavioral treatment of obesity. [2022]
Comparison of an alternative schedule of extended care contacts to a self-directed control: a randomized trial of weight loss maintenance. [2021]
Behavioral intervention for the obese client. [2019]
Personalized multistep cognitive behavioral therapy for obesity. [2020]
Perceived helpfulness of the individual components of a behavioural weight loss program: results from the Hopkins POWER Trial. [2021]
Impact of program characteristics on weight loss in adult behavioral weight management interventions: systematic review and component network meta-analysis. [2022]
Outcomes and utilization of a low intensity workplace weight loss program. [2021]
Attrition Bias in an Observational Study of Very Low-Energy Diet: A Cohort Study. [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
Behavioral management of obesity. [2019]
Multidisciplinary approach to adult obesity therapy. [2014]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security